Join
Live feed
·
PRReleasevia Quantisnow
NextCure Inc. logo

NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers

ByQuantisnow·Wall Street's wire, on your screen.
NXTC· NextCure Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NXTC (NextCure Inc.) and more on Quantisnow.